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Background: microRNAs are small non-coding RNA that control gene expression by mRNA 
degradation or translational inhibition. These molecules are known to play essential roles in 
many biological and physiological processes. miR-205 may be differentially expressed in head 
and neck cancers; however, there are conflicting data and localization of expression has yet to 
be determined.  
Materials and Methods: miR-205 expression was investigated in 48 cases of inflammatory, 
benign and malignant tumor tissue array of the neck, oronasopharynx,larynx and salivary 
glands by Locked Nucleic Acid in situ hybridization (LNA-ISH) technology. 
Results: miR-205expression was significantly differentially expressed across all of the 
inflammatory, benign and malignant tumor tissues of the neck. A significant increase in miR-
205 staining intensity (p<0.05) was observed from inflammation to benign and malignant 
tumors in head and neck tissue array, suggesting that miR-205 could be a biomarker to 
differentiate between cancer and non-cancer tissues. 
Conclusions: LNA-ISH revealed that miR-205 exhibited significant differential cytoplasmic 
and nuclear staining among inflammation, benign and malignant tumors of head and neck. 
miR-205 was not only exclusively expressed in squamous epithelial malignancy. This study 
offers information and a basis for a comprehensive study of the role of miR-205 that may be 
useful as a biomarker and/or therapeutic target in head and neck tumors. 
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